WCBA
Weaver C. Barksdale & Associates’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Sell |
21,070
-80
| -0.4% | -$8.87K | 2.24% | 5 |
|
|
2025
Q1 | $2.37M | Sell |
21,150
-2,505
| -11% | -$281K | 2.27% | 4 |
|
|
2024
Q4 | $2.19M | Sell |
23,655
-613
| -3% | -$56.6K | 2.09% | 14 |
|
|
2024
Q3 | $2.03M | Sell |
24,268
-941
| -4% | -$78.9K | 1.83% | 20 |
|
|
2024
Q2 | $1.73M | Sell |
25,209
-337
| -1% | -$23.1K | 1.64% | 33 |
|
|
2024
Q1 | $1.87M | Sell |
25,546
-200
| -0.8% | -$14.6K | 1.72% | 27 |
|
|
2023
Q4 | $2.09M | Sell |
25,746
-6,786
| -21% | -$550K | 2.04% | 14 |
|
|
2023
Q3 | $2.44M | Buy |
32,532
+5,259
| +19% | +$394K | 2.08% | 9 |
|
|
2023
Q2 | $2.1M | Sell |
27,273
-1,680
| -6% | -$129K | 2.08% | 7 |
|
|
2023
Q1 | $2.4M | Sell |
28,953
-1,151
| -4% | -$95.5K | 2.25% | 1 |
|
|
2022
Q4 | $2.58M | Buy |
30,104
+815
| +3% | +$70K | 2.28% | 1 |
|
|
2022
Q3 | $1.81M | Buy |
+29,289
| New | +$1.81M | 1.81% | 16 |
|